Mikayama et al. Proc. Natl. Acad. Sci. USA vol. 90, pp. 10056-10060, 1993.* |
Voet et al. Biochemistry, John Wiley & Sons, Inc., pp. 126-128 and 228-234.* |
E Barnard E.. A. (1996). The transmitter-gated channels: a range of receptor types and structures. Trends Pharmacol. Sci. 17, 305-309. |
Belelli, D., Balcarek, J. M., Hope, A. G., Peters, J. A., Lambert, J. J., and Blackburn, T. P. (1995). Cloning and functionaBelelll expression of a human 5-hydroxytrypstamine type 3 As receptor subunit. Mol. Pharmacol. 48, 1054-62. |
Boess, F. G., Steward, L. J., Steele, J. A., Liu, D., Reid, J., Glencorse, T. A., and Martin, I. L. (1997). Analysis of the ligand binding site of the 5-HT3 receptor using site directed mutagenesis: importance of glutamate 106. Neuropharmacology 36, 637-647. |
Bufton, K. E., Steward, L. J., Barber, P. C., and Barnes, N. M. (1993). Distribution and characterization of the [3H]granisetron-labeled 5-HT3 receptor in the human forebrain. Neuropharmacology 32, 1325-31. |
Davies, P. A., Pistis, M., Hanna, M. C., Peters, J. A., Lambert, J. J., Hales, T. G., and Kirkness, E. F. (1999). The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature (London) 397, 359-363. |
Derkach, V., Surprenant, A., and North, R. A. (1989). 5-HT3 receptors are membrane ion channels. Nature (London) 339, 706-9. |
Fletcher, S., and Barnes, N. M. (1998). Desparately seeking subunits: are native 5-H receptors really homomeric complexes? Trends Pharmacol. Sci. 19, 212-215. |
Fletcher, S., and Barnes, N. M. (1997). Purification of 5-hydroxytryptamine3 receptors from porcine brain. Br. J. Pharmacol. 122, 655-662. |
Fletcher, S., Lindstrom, J. M., Mckernan, R. M., and Barnes, N. M. (1998). Evidence that porcine native 5-HT3 receptors do not contain nicotinic acetylcholine receptor subunits. Neuropharmacology 37, 397-399. |
Furutani, M., Trudeau, M. C., Hagiwara, N., Seki, A., Gong, Q., Zhou, Z., Imamura, S.-i., Nagashima, H., Kasanuki, H., Takao, A., Momma, K., January, C. T., Robertson, G. A., and Matsuoka, R. (1999). Novel mechanism associated with an inherited cardiac arrhythmia: Defective protein trafficking by the mutant HERG (G601S) potassium channel. Circulation 99, 2290-2294. |
Gralla, R. J. (1998). Antiemetic therapy. Semin. Oncol. 25, 577-583. |
Greenshaw, A. J., and Silverstone, P. H. (1997). The non-antiemetic uses of serotonin 5-HT3 receptor antagonists: clinical pharmacology and therapeutic applications. Drugs 53, 20-39. |
Gurley, D. A., and Lanthorn, T. H. (1998). Nicotinic agonists competitively antagonized serotonin at mouse 5-HT3 receptors expressed in Xenopus oocytes. Neurosci. Lett. 247, 107-110. |
Hugnot, J.-P., Salinas, M., Lesage, F., Guillemare, E., de Weille, J., Heurteaux, C., Mattei, M.-G., and Lazdunski, M. (1996). Kv8.1, a new neuronal potassium channel subunit with specific inhibitory properties towards Shab and Shaw channels. Embo J. 15, 3322-3331. |
Jan, L. Y., and Jan, Y. N. (1997). Voltage-gated and inwardly rectifying potassium channels. In J. Physiol. (Cambridge, U. K.), pp. 267-282. |
Lambert, J. J., Peters, J. A., and Hope, A. G. (1995). 5-HT3 receptors. In Ligand- Voltage-Gated Ion Channels, R. North, ed.: CRC, Boca Raton, Fla), pp. 177-211. |
Lummis, S. C. R., and Baker, J. (1997). Radioligand binding and photoaffinity labeling studies show a direct interaction of phenothiazines at 5-HT3 receptors. Neuropharmacology 36, 665-670. |
Lummis, S. C. R., and Martin, I. L. (1992). Solubilization, purification, and functional reconstitution of 5-hydroxytryptamine3 receptors from N1E-115 neuroblastoma cells. Mol. Pharmacol. 41, 18-23. |
Lummis, S. C. R., Sepulveda, M. I., Kilpatrick, G. J., and Baker, J. (1993). Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells. Eur. J. Pharmacol. 243, 7-11. |
Maricq, A. V., Peterson, A. S., Brake, A. J., Myers, R. M., and Julius, D. (1991). Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science (Washington, D. C., 1883-) 254, 432-7. |
Mathur, R., Zhou, J., Babila, T., and Koren, G. (1999). Ile-177 and Ser-180 in the S1 segment are critically important in Kv1.1 channel function. J. Biol. Chem. 274, 11487-11493. |
Miller, K., Weisberg, E., Fletcher, P. W., and Teitler, M. (1992). Membrane-bound and solubilized brain 5HT3 receptors: improved radioligand binding assays using bovine area postrema or rat cortex and the radioligands 3H-GR65630, 3H-BRL43694, and 3H-LY278584. Synapse (N. Y.) 11, 58-66. |
Miyake, A., Mochizuki, S., Takemoto, Y., and Akuzawa, S. (1995). Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. Mol. Pharmacol. 48, 407-16. |
Passani, M. B., and Corradetti, R. (1996). Therapeutic potentials of itasetron (AU 6215), a novel 5-HT3 receptor antagonist, in the treatment of central nervous system disorders. CNS Drug Rev. 2, 195-213. |
Peters, J. A., Malone, H. M., and Lambert, J. J. (1992). Recent advances in the electrophysiological characterization of 5-HT3 receptors. Trends Pharmacol. Sci. 13, 391-7. |
Salinas, M., de Weille, J., Guillemare, E., Lazdunski, M., and Hugnot, J.-P. (1997). Modes of regulation of Shab K+ channel activity by the Kv8.1 subunit. J. Biol. Chem. 272, 8774-8780. |
Salinas, M., Duprat, F., Heurteaux, C., Hugnot, J.-P., and Lazdunski, M. (1997). New modulatory a subunits for mammalian Shab K+ channels. J. Biol. Chem. 272, 24371-24379. |
Shalaby, F. Y., Levesque, P. C., Yang, W.-P., Little, W. A., Conder, M. L., Jenkins-West, T., and Blanar, M. A. (1997). Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation 96, 1733-1736. |
Shuck, M. E., Piser, T. M., Bock, J. H., Slightom, J. L., Lee, K. S., and Bienkowski, M. J. (1997). Cloning and characterization of two K + inward rectifier (Kir) 1.1 potassium channel homologs from human kidney (Kirl.2 and Kirl.3). J. Biol. Chem. 272, 586-593. |
Steward, L. J., West, K. E., Kilpatrick, G. J., and Barnes, N. M. (1993). Labeling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand ([3H]meta-chlorophenylbiguanide. Eur. J. Pharmacol. 243, 13-18. |
Stocker, J., Hellwig, M., and Kerschensteiner, D. (1999). Subunit assembly and domain analysis of electrically silent K+ channel a-subunits of the rat Kv9 subfamily. J. Neurochem. 72, 1725-1734. |
Sugita, S., Shen, K. Z., and North, R. A. (1992). 5-Hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala. Neuron 8, 199-203. |
Turton, S., Gillard, N. P., Stephenson, F. A., and McKernan, R. M. (1993). Antibodies against the 5-HT3-A receptor identify a 54 kDa protein affinity-purified from NCB20 cells. Mol. Neuropharmacol. 3, 167-71. |
Van Hooft, J. A., and Vijverberg, H. P. M. (1995). Phosphorylation controls conductance of 5-HT3 receptor ligand-gated ion channels. Recept. Channels 3, 7-12. |
Waeber, C., Shoeffter, P., Hoyer, D., and Palacios, J. (1989). 5-HT3 receptors in the human brain- autoradiographic visualisation using [3H] ICS 205-930. Neuroscience 31, 393. |
Yakel, J. L., Shao, X. M., and Jackson, M. B. (1991). Activation and desensitization of the 5-HT3 receptor in a rat glioma .times. mouse neuroblastoma hybrid cell. J. Physiol. (London) 436, 293-308. |
Zerr, P., Adelman, J. P., and Maylie, J. (1998). Episodic ataxia mutations in Kvl.1 alter potassium channel function by dominant negative effects or haploinsufficiency. J. Neurosci. 18, 2842-2848. |
Shuck, Mary E.; Piser, Timothy M.; Bock, Jeffery H.; Slightom, Jerry L.; Lee, Kai S.; and Bienkowski, Michael J., “Cloning and Characterization of Two K+ Inward Rectifier (Kir) 1.1 Potassium Channel Homologs from Human Kidney (Kir1.2 and Kir1.3)”, The Journal of Biological Chemistry, 1997, 586-593, vol. 272, No. 1, The American Society for Biochemistry and Molecular Biology, Inc., U.S.A. |
Mathur, Rajesh; Zhou, Jun; Babila, Tamar; and Koren, Gideon, “lle-177 and Ser-180 in the S1 Segment are Critically Important in Kv1.1 Channel Function”, The Journal of Biological Chemistry, 1999, 11487-11493, vol. 274, No. 17, The American Society for Biochemistry and Molecular Biology, Inc., U.S.A. |
Stocker, Martin; Hellwig, Michaela; and Kerschensteiner, Daniel, “Subunit Assembly and Domain Analysis of Electrically Silent K+ Channel (alpha)-Subunits of the Rat Kv9 Subfamily”, Journal of Neurochemistry, 1999, 1725-1734, vol. 72(4), Lippincott, Williams & Wilkins. |
Zerr, Patricia; Adelman, John P.; and Maylie, James, “Episodic Ataxia Mutations in Kv1.1 Alter Potassium Channel Function by Dominent Negative Effects or Haploinsufficiency”, The Journal of Neuroscience, 1998, 2842-2848, vol. 18(8), Society for Neuroscience. |
Shalaby, Fouad Y.; Levesque, Paul C.; Yang, Wen-Pin; Little, Wayne A.; Conder, Mary Lee; Jenkins-West, Tonya; and Blanar, Michael A., “Dominant-Negative KvLQT1 Mutations Underlie the LQT1 Form of Long QT Syndrome”, Circulation, 1997, 1733-1736, vol. 96(6), Lippincott, Williams & Wilkins. |
Furutani, Michiko; Trudeau, Matthew C.; Hagiwara, Nobuhisa; Seki, Akiko; Gong, Qiuming; Zhou, Zhengfeng; Imamura, Shin-ichiro; Nagashima, Hirotaka; Kasanuki, Hiroshi; Takao, Atsuyoshi; Momma, Kazuo; January, Craig T.; Robertson, Gail A.; and Matsuoka, Rumiko, “Novel Mechanism Associated with an Inherited Cardiac Arrhythmia: Defective Protein Trafficking by the Mutant Herg (G601S) Potassium Channel”, Circulation, 1999, 2290-2294, vol. 99(17), Lippincott, Williams & Wilkins. |
Salinas, Miguel; Duprat, Fabrice; Heurteaux, Catherine; Hugnot, Jean-Philippe; and Lazdunski, Michel, “New Modulatory α Subunits for Mammalian Shab K+ Channels”, The Journal of Biological Chemistry, 1997, 24371-24379, vol. 272, No. 39, The American Society for Biochemistry and Molecular Biology, Inc., U.S.A. |
Hugnot, Jean-Philippe; Salinas, Miguel; Lesage, Florian; Guillemare, Eric; De Weille, Jan; Heurteaux, Catherine; Mattel, Marie-Genevieve; and Lazdunski, Michel, “Kv8.1, A New Neuronal Potassium Channel Subunit with Specific Inhibitory Properties Towards Shab and Shaw Channels”, The EMBO Journal, 1996, 3322-3331, vol. 15, No. 13, Oxford University Press. |
Salinas, Miguel; De Weille, Jan; Guellemare, Eric; Lazdunski, Michel; and Hugnot, Jean-Philippe, “Modes of Regulation of Shab K+Channel Activity by the Kv8.1 Subunit”, The Journal of Biological Chemistry, 1997, 8774-8780, vol. 272, No. 13, The American Socity for Biochemistry and Molecular Biology, Inc., U.S.A. |
Jan, Lily Yeh and Jan, Yuh Nung, “Voltage-Gated and Inwardly Rectifying Potassium Channels”, Journal of Physiology, 1997, 267-282, vol. 505, No. 2. |
Sugita, S.; Shen, K.-Z.; and North, R.A., “5-Hydroxytryptamine is a Fast Excitatory Transmitter at 5-HT3 Receptors in Rat Amygdala”, Neuron, 1992, 199-203, vol. 8, Cell Press. |
Greenshaw, Andrew J and Silverstone, Peter H., “The Non-Antiemetic Uses of Serotonin 5-HT3 Receptor Antagonists”, Drugs, 1997, 20-39, vol. 53(1), Adis International Limited. |
Bufton, Kate E.; Steward, Lucinda J.; Barber, Peter C.; and Barnes, Nicholas M., “Distribution and Characterization of the [3H]Granisetron-Labelled 5-HT3 Receptor in the Human Forebrain”, Neuropharmacology, 1993, 1325-1331, vol. 32, No. 12, Pergamon Press Ltd., Great Britain. |